The Children's Hour

More than a fifth of the people in the European Union are age 16 or under, yet at least half of the medicines in use there have not been tested o­n children. As a result, the region suffers from a lack of information about the safety and efficacy of pediatric medicines and of off-label pediatric use that medical experts say could cause adverse effects and even death.

For full article
Click Here

Author(s): 
Kevin Gopal .
Journal: 
Pharmaceutical Executive, Apr 1, 2002.